Market News & Trends
Bristol-Myers Squibb & Merck in Race to Dominate Head & Neck Cancer Market
Bristol-Myers Squibb & Merck in Race to Dominate Head & Neck Cancer Market Bristol-Myers Squibb (BMS) and Merck & Co. are set to continue…
INTERPHEX & Industry Experts Select Nemera as Winner for Best New Product
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral…
Merrimack Unveils Its Latest Antibody-Directed Nanotherapeutic
Merrimack Pharmaceuticals, Inc. recently announced positive data from preclinical studies evaluating MM-310, an antibody-directed nanotherapeutic (ADN) that encapsulates a newly engineered form of the highly…
Baxter International Initiates Offer to Exchange Shares of Baxter for Shares of Baxalta
Baxter International Inc. and Baxalta Incorporated recently announced that Baxter has commenced an offer to exchange up to 12,800,000 shares of Baxalta common stock that…
Patheon Selected by Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with Grünenthal, an independent, family-owned, international…
New Structure Identified in Membrane of Disease-Causing Bacteria
Mycobacteria cause a number of dangerous, difficult-to-treat diseases including leprosy and tuberculosis, and progress has been slow in eradicating them. But new strategies for combating…
New Potential Lung Cancer Biomarkers Identified by The West Virginia University Cancer Institute
Protea Biosciences Group, Inc. recently announced the use of its proprietary bioanalytical technology to achieve the molecular profiling of live tumor cells while they are…
MorphoSys Licensing Partner GSK Starts Phase II Study
MorphoSys AG recently announced its licensing partner GlaxoSmithKline (GSK) has initiated a Phase II clinical study to investigate the effectiveness and safety of GSK3196165 (previously…
Multi-Blockbuster Drugs Will Drive Immuno-Oncology Market to $34 Billion by 2024
The total immuno-oncology market will be worth approximately $14 billion by 2019, rising to $34 billion by 2024, as the treatment of cancer patients undergoes…
Patheon Selected By Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with Grünenthal, an independent, family-owned,…
AAI Pharma Services Corporation & Cambridge Major Laboratories Are Now Alcami
AAIPharma Services Corporation (AAI) / Cambridge Major Laboratories, Inc. (CML), a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, recently announced its…
Aptar Pharma Launches eDose Counter for MDIs Integrating Proprietary Sensing Technology
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection, and spray delivery systems for biotech, healthcare, and pharma products, will unveil…
FDA Accepts for Priority Review Bristol-Myers Squibb’s Supplemental Biologics License Application for Opdivo
Bristol-Myers Squibb Company recently announced the US FDA accepted a supplemental Biologics License Application (sBLA), which seeks to expand the use of Opdivo to patients…
Presage Biosciences Extends Research Collaboration With Takeda
Presage Biosciences recently announced it has entered into a multi-year extension of its November 2014 research alliance with Takeda Pharmaceuticals Company Limited. The agreement provides…
Pluristem Continues to Strengthen its Position in Japan; Granted Two Key
Pluristem Therapeutics Inc. recently announced that the Japan Patent Office has granted the Company two key patents addressing: 1) Pluristem’s core technology of three-dimensional expansion…
N-of-One Selected by Admera Health to Provide Clinical Interpretation for the OncoGxOne 64-Gene Oncology Panel
N-of-One, Inc. recently announced that Admera Health has selected N-of-One to provide clinical interpretation of their 64-gene oncology panel, OncoGxOne. N-of-One’s patient-specific analysis is based…
Genomics plc & DNAnexus Collaborate to Develop Solutions for Population-Scale Sequencing Analysis
Genomics plc recently announced it has entered into a research collaboration with DNAnexus, the global leader in cloud-based genome informatics and data management. The companies…
Actinium Announces Selection of Zevacor for Clinical Production & Supply Pivotal Phase III Trial
Actinium Pharmaceuticals, Inc. recently announced the company has entered into an agreement with Zevacor Pharma, Inc. (formerly IBA Molecular North America, Inc.) for the clinical…
World Excipients Market Expected to Reach $6.4 Billion by 2020
A new report published by Allied Market Research titled World Excipients Market-Opportunities and Forecasts, 2014-2020 projects that the world excipients market would reach $6.4 billion…
Global Viral Infections Market to Reach $117.6 Billion
The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a compound annual growth rate of 6.8%,…
